AIMC Journal:
Biomolecules & therapeutics

Showing 1 to 4 of 4 articles

Artificial Intelligence in Mass Spectrometry-Based Metabolomics and Lipidomics for Drug Discovery and Development.

Biomolecules & therapeutics
Artificial intelligence applied to mass spectrometry-based metabolomics and lipidomics has advanced through three technological generations: chemometric and classical machine learning, deep learning, and self-supervised foundation models, with large ...

Mechanistic and Clinical Perspectives on Traditional Chinese Medicine in Thyroid Cancer Management.

Biomolecules & therapeutics
Thyroid cancer is one of the most prevalent malignancies of the endocrine system, comprising various subtypes such as papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), medullary thyroid carcinoma (MTC), and the aggressive anaplas...

Evidence-Based Strategies for Addressing Cancer- and Treatment-Related Cognitive Impairment: A Review.

Biomolecules & therapeutics
Cancer-related cognitive impairment (CRCI) has become a notable long-term consequence for cancer survivors, especially among those receiving chemotherapy, radiotherapy, or targeted treatments. Despite the advances in the treatment of cancer, CRCI sti...

Current and Emerging Therapies Targeting the IL-23/IL-17 Axis in Psoriasis.

Biomolecules & therapeutics
Over the past two decades, experimental and clinical evidence has established the interleukin-23 (IL-23)/interleukin-17 (IL-17) axis as a key mediator of psoriatic inflammation. IL-23, primarily derived from activated dendritic cells, supports the su...